CASC9 and central nervous system cancer: Given the association of tumor recurrence and drug resistance, expression patterns of RMRP, HOXA-AS3, and CASC9 were examined in tumor tissues isolated from glioma patients without any treatment (n = 20) and glioma patients suffered from recurrence post-treatment (n = 12).